{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-081482","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.503774+00:00","generated_at":"2026-05-31T02:07:27.714882+00:00","sec_items":["3.01","3.02","3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Onconetix effects 1:40 reverse stock split; Nasdaq delisting notice resolved via new listing approval","bullets":["Reverse stock split at ratio 1:40 effective Sept. 24, 2024; no fractional shares issued, cash paid in lieu.","Nasdaq delisting notice for bid price non-compliance received Sept. 18; mooted by Sept. 19 approval of new listing application meeting $4 closing bid price.","Issued 142,749 shares to Veru upon conversion of Series A Preferred; 6,741,820 shares to former Proteomedix holders on Series B automatic conversion.","Issued 513,424 units (share + warrant) to Altos plus 154,027 shares on warrant exercise; all exempt from registration.","Post-split shares outstanding: 8,307,051 total (including 2,656 unvested restricted stock)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-081482","json":"https://secwatch.observer/filing/0001213900-24-081482.json","markdown":"https://secwatch.observer/filing/0001213900-24-081482.md","text":"https://secwatch.observer/filing/0001213900-24-081482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024081482/0001213900-24-081482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024081482/ea0215560-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:07:27.714882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}